High 8.8Published Jun 2, 2026

CVE-2026-9844Use of default credentials vulnerability in Roche Diagnostics navify Digital Pathology (RabbitMQ Management interface modules) allows Default Usernames and Passwords.

Updated under an hour ago (2026-10-19 07:50 UTC)

Does this affect you?

It lists no affected products yet. Add what you run and Signals checks it as products are added.

No exploitation reported and no EPSS estimate yet.

Do this next

Start free and add your stack

Free account, 1 product

Exploited in the last 30 days

Use of default credentials vulnerability in Roche Diagnostics navify Digital Pathology (RabbitMQ Management interface modules) allows Default Usernames and Passwords. This issue affects navify Digital Pathology: from 2.0.0 before 2.4.1.

CVSS: 8.8 HIGH (v4.0, NVD)CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:H/VA:H/SC:L/SI:L/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:N/AU:Y/R:U/V:D/RE:M/U:Green
Weakness (CWE): CWE-1392
Known exploited: Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days): Not loaded for this CVE
Assigned by: Not given
NVD analysis: Deferred
Record last updated: Jul 22, 2026
First seen by InfoSec Signals: Oct 9, 2026

Affected products

No affected products are listed yet.

References

https://diagnostics.roche.com/global/en/legal/product-security-advisory.html

The CVE record on cve.org NVD's entry

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.